Concepedia

Patrick Nadolny

PN

Statistics

Publications

4

Citations

108

H-Index

4

Active since

2003

Affiliations

Allergan (United States)(Current)

Center for Global Development

Eli Lilly (United States)

Patrick Nadolny is an author at Allergan (United States) specializing in clinical trials, clinical trial protocol review, and good clinical practice.

Publications per year

2003–2020

4

Publications

4

Evaluating Source Data Verification as a Quality Control Measure in Clinical Trials

Nicole Sheetz, Brett Wilson, Joanne Benedict et al. · Therapeutic Innovation & Regulatory Science · 2014 · 48 citations · Full text

, , +16

Detecting Data Quality Issues in Clinical Trials: Current Practices and Recommendations

David Knepper, Christian Fenske, Patrick Nadolny et al. · Therapeutic Innovation & Regulatory Science · 2015 · 30 citations · Full text

, , +15

Quality Tolerance Limits: Framework for Successful Implementation in Clinical Development

Ruma Bhagat, Łukasz Bojarski, Soazig Chevalier et al. · Therapeutic Innovation & Regulatory Science · 2020 · 20 citations · Full text

, , +8

A phase 1 study of tazarotene in adults with advanced cancer

Philip H. Jones, R D Burnett, I Fainaru et al. · British Journal of Cancer · 2003 · 10 citations · Full text

, , +14

1–4 of 4